Language: English
Sickle cell disease (SCD) is a complex disorder that requires multiple players working to improve outcomes in the short- and long-term. Learn below how three entities – the SCD Coalition (SCDC); American Society of Hematology (ASH); and the National Academies of Science, Engineering, and Medicine (NASEM) – are tracking progress and strategizing to conquer SCD.
The SCD Coalition uses a multi-faceted, community-centered approach within its subcommittees, addressing key priority areas.
Learn MoreFollowing the establishment of key priorities at the 2015 SCD Stakeholder Summit, ASH launched a series of report cards to provide a snapshot of progress and ongoing challenges across priority areas— helping guide future action and accountability.
Learn More
In 2020, NASEM released a pivotal report entitled, "Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action."
Learn More
